Why Should You Attend:
Both sponsors who undertake clinical trials with investigational devices and the institutions that host them take on obligations and risks that are unlike those related to investigational drug studies. To proceed without an in depth knowledge of these matters can expose institutions, investigators and sponsors to risks that can easily be managed with a good understanding of the issues.
The regulations governing Investigational Device (IDE) studies are distinct in many respects from those governing investigational drug (IND) studies. Likewise, the processes created to carry them out are distinct and require and a good understanding of those differences is essential to compliant and successful studies.
This session will offer an overview of where the regulations diverge and how this impacts the design and execution of device studies. Additional issues related to device studies, such as Medicare approval and reimbursement, billing and coding and other areas of risk will be discussed. This course is recommended for both those experienced in device studies and those just now entering the field.
At the end of this session, attendees will be able to:
Areas Covered in the Seminar:
Who Will Benefit:
This webinar will provide valuable assistance to all personnel involved in the research enterprise, including:
Bob Romanchuk, is a clinical research professional with over a decade of experience in a broad range of clinical research infrastructure building, operation and management of both IRBs and research programs. This includes assembling and managing an IRB, building a cardiovascular research center for a large community hospital and creation and operation of a central research office for a 13 hospital system across North Carolina, South Carolina and Virginia. His certifications include CIP (Certified IRB Professional), CHRC (Certification in Health Research Compliance), CCRC (Certified Clinical Research Coordinator) and CCRCP (Certified Clinical Research Contract Professional). He has presented numerous times nationally on the subjects of clinical trial billing, human subjects protections and the creation and operation of centralized research offices.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
6201 America Center Drive Suite 240, San Jose, CA 95002, USA
PAYMENT METHOD: 100% Secure Transaction